Table 5.
Parameter | Relative Risk (RR) | Confidence Limits | P-value |
---|---|---|---|
Lightly adjusted model* | |||
Baseline Tricyclic Antidepressant Use (n=38) | 1.24 | 1.06 to 1.44 | 0.0065 |
Baseline non-Tricyclic Antidepressant Use (n=193) | 1.02 | 0.96 to 1.08 | 0.5976 |
CESD Score (per unit) ‡ | 1.000 | 0.998 to 1.002 | 0.8840 |
Fully Adjusted Model† | |||
Baseline Tricyclic Antidepressant Use (n=38) | 1.20 | 1.05 to 1.37 | 0.0090 |
Baseline non-Tricyclic Antidepressant Use (n=193) | 0.99 | 0.93 to 1.04 | 0.6282 |
CESD Score (per unit)‡ | 1.000 | 0.997 to 1.002 | 0.8071 |
adjusted for age, sex and ethnicity.
adjusted for age, sex, ethnicity, smoking, alcohol use, diabetes, body mass index, exercise (intentional and sedentary), Spielberger anxiety and anger scores, health insurance, income and baseline systolic and diastolic blood pressure
Note that CESD is a continuous variable in this analysis and not a indicator of CES-D ≥ 16; the binary variable would also have tested as non-significant.